Multiparametric magnetic resonance imaging has become an established method for evaluating the prostate for clinically significant prostate adenocarcinoma. Criteria have been developed for categorizing MRI findings, the most frequently used of which is the PI-RADS system. The PI-RADS V2 document provides separate image interpretation and clinical grading sections. Within this article we give an overview of the integrated, algorithmic way, we approach prostate MRI, show images corresponding to each PI-RADS category, and provide several illustrative cases.
This is a preview of subscription content, log in to check access.
Buy single article
Instant unlimited access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
PI-RADS™ Prostate Imaging-Reporting and Data System Version 2. (2015). http://www.acr.org/~/media/ACR/Documents/PDF/QualitySafety/Resources/PIRADS/PIRADS%20V2.pdf. Accessed 11/19/2015
Vargas HA, Hotker AM, Goldman DA, et al. (2015) Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference. Eur Radiol. doi:10.1007/s00330-015-4015-6
Zhang ZX, Yang J, Zhang CZ, et al. (2014) The value of magnetic resonance imaging in the detection of prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels: a meta-analysis. Acad Radiol 21(5):578–589. doi:10.1016/j.acra.2014.01.004
Moore CM, Robertson NL, Arsanious N, et al. (2013) Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol 63(1):125–140. doi:10.1016/j.eururo.2012.06.004
Abdi H, Zargar H, Goldenberg SL, et al. (2015) Multiparametric magnetic resonance imaging-targeted biopsy for the detection of prostate cancer in patients with prior negative biopsy results. Urol Oncol 33(4):e161–e167. doi:10.1016/j.urolonc.2015.01.004
Abdi H, Pourmalek F, Zargar H, et al. (2015) Multiparametric magnetic resonance imaging enhances detection of significant tumor in patients on active surveillance for prostate cancer. Urology 85(2):423–428. doi:10.1016/j.urology.2014.09.060
Puech P, Rouviere O, Renard-Penna R, et al. (2013) Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy–prospective multicenter study. Radiology 268(2):461–469. doi:10.1148/radiol.13121501
Tamada T, Kanomata N, Sone T, et al. (2014) High b value (2,000 s/mm2) diffusion-weighted magnetic resonance imaging in prostate cancer at 3 Tesla: comparison with 1000 s/mm2 for tumor conspicuity and discrimination of aggressiveness. PloS One 9(5):e96619. doi:10.1371/journal.pone.0096619
Conflict of interest
None of the authors reported conflicts of interest for this paper.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
This is a review article/pictorial essay, and informed consent was not needed since only images which were already obtained were used.
About this article
Cite this article
Horn, G.L., Hahn, P.F., Tabatabaei, S. et al. A practical primer on PI-RADS version 2: a pictorial essay. Abdom Radiol 41, 899–906 (2016). https://doi.org/10.1007/s00261-016-0705-z
- Magnetic resonance imaging
- Prostatic neoplasms